Article By:
Schaeffers Research
Wednesday, June 16, 2021 12:23 PM EDT
Wall Street is holding its collective breath ahead of the conclusion of the Federal Reserve's two-day policy meeting, with stocks reflecting that muted sentiment at midday, as investors await comments from Fed Chairman Jerome Powell.
Inhibikase Therapeutics: A Novel And Promising Approach To Neurodegeneration And Oncology
Bio Deep Dives, very thorough piece on #Inhibikase. But could you go into more depth about the competative landscape? Intersted in $IKT but wondering how the competition measures up.
Inhibikase Therapeutics: A Novel And Promising Approach To Neurodegeneration And Oncology
Bullish on $IKT
Inhibikase Targets A Substantial Market Following Results Presented At The Barcelona Conference
Good analysis. Sounds like there's tremendous potential for $IKT!